Effect of Daily Interruption of Continuous Sedation on Delirium, Sleep Perception in Intensive Care Unit (ICU) Patients (ICUDelirium)
Primary Purpose
Delirium, Sleep Perception
Status
Completed
Phase
Early Phase 1
Locations
Puerto Rico
Study Type
Interventional
Intervention
Normal continuous sedation
Daily interruption of continuous sedation
Sponsored by
About this trial
This is an interventional treatment trial for Delirium focused on measuring sedation, delirium, sleep, sedation withdrawal, ICU patients
Eligibility Criteria
Inclusion Criteria:
- Patients ≥ 21 years will be recruited from a Trauma Intensive Care Unit of Puerto Rico. This unit receives critically ill patients with three or more affected body systems involved after motor vehicle accident, gunshot injury, penetrating injury, and falls.
Exclusion Criteria:
- Baseline neurological diseases
- Head trauma or acute neurological injury with Glasgow Coma Scale score < 8
- Death expected within 24 hours (APACHE II ≥ 30)
- History of alcoholism
- History of drug dependence
- Deaf and blind patients
Sites / Locations
- Trauma Unit University of Puerto Rico Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Experimental
Arm Label
1
2
Arm Description
Patients in the control group will receive continuous sedative infusions without daily interruption of sedatives based on the standard clinical practice of the TICU.
Patients in the intervention group will receive daily interruption of sedative.
Outcomes
Primary Outcome Measures
Delirium and sleep
Secondary Outcome Measures
Full Information
NCT ID
NCT00714194
First Posted
June 16, 2008
Last Updated
May 6, 2015
Sponsor
University of California, San Francisco
1. Study Identification
Unique Protocol Identification Number
NCT00714194
Brief Title
Effect of Daily Interruption of Continuous Sedation on Delirium, Sleep Perception in Intensive Care Unit (ICU) Patients
Acronym
ICUDelirium
Official Title
The Effect of Daily Interruption of Continuous Sedation on the Occurrence of Delirium and Perception of Sleep in ICU Patients
Study Type
Interventional
2. Study Status
Record Verification Date
May 2015
Overall Recruitment Status
Completed
Study Start Date
July 2008 (undefined)
Primary Completion Date
September 2009 (Actual)
Study Completion Date
September 2009 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, San Francisco
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This is an intervention study whose purpose is to determine whether daily interruption of sedative infusion contributes to the reduction of the occurrence of delirium and improves sleep perception in critically ill patients. Patients in a trauma intensive care unit (TICU) receiving mechanical ventilation and continuous infusion of sedatives will be enrolled in the study. A patient will be entered into the study after the family member has consented to have the patient participate.
Detailed Description
This is an intervention study whose purpose is to determine whether daily interruption of sedative infusion contributes to the reduction of the occurrence of delirium and improves sleep perception in critically ill patients. Patients in a trauma intensive care unit (TICU) receiving mechanical ventilation and continuous infusion of sedatives will be enrolled in the study. A patient will be entered into the study after the family member has consented to have the patient participate. A sequential assignment method will be used to compare two groups of 20 patients in each group. The first group of 20 patients (control group [CG]) to be studied will receive continuous sedative infusion without daily interruption. The second group of 20 patients (intervention group [IG]) will receive a daily interruption of sedative infusion.
If control and intervention group data are not sufficient to elicit the effect of daily interruption of sedatives, data collection will continue using the sequential assignment method alternating control and intervention group 10 patients at a time. This method will proceed until an effect is detected or until the a priori sample size of 182 (i.e., 91 patients per group) has been reached.
The intervention group will be monitored during the daily interruption of sedative infusion (i.e., sedation wake-up trial[SWT])in order to measure the following variables: delirium, physiological response (heart rate [HR], respiratory rate [RR], blood pressure [BP], and pulse oxygen saturation [SpO2]), pain intensity, and agitation/sedation level.Once the patient is awake during the SWT period, the patient will be screened for SBT. If the patient meets the SBT criteria, then the mechanical ventilator mode will be changed to continuous positive airway pressure (CPAP) or the patient will be placed in a T-tube circuit for 2 hours or until the patient presents signs of SBT failure. Delirium will be measured 3 times a day for a maximum of 3 days in both groups after continuous deep sedation discontinuation using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Sleep perception will be measured by a sleep questionnaire (Sleep Perception in the ICU) after discontinuous of continuous sedation. Agitation/sedation level will be measured with the Richmond Agitation-Sedation Scale (RASS) and Bispectral Index (BIS), and pain intensity with a 0 to 10 numeric rating scale (NRS).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Delirium, Sleep Perception
Keywords
sedation, delirium, sleep, sedation withdrawal, ICU patients
7. Study Design
Primary Purpose
Treatment
Study Phase
Early Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
52 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Other
Arm Description
Patients in the control group will receive continuous sedative infusions without daily interruption of sedatives based on the standard clinical practice of the TICU.
Arm Title
2
Arm Type
Experimental
Arm Description
Patients in the intervention group will receive daily interruption of sedative.
Intervention Type
Procedure
Intervention Name(s)
Normal continuous sedation
Intervention Description
Normal continuous sedation.
Intervention Type
Other
Intervention Name(s)
Daily interruption of continuous sedation
Other Intervention Name(s)
Ativan®, Versed®, Driprivan®
Intervention Description
Withdrawal of normal continuous sedation with Lorazepam, Midazolam, and Propofol from 7:00 am to 8:00 am daily until continuous sedation discontinuation.
Primary Outcome Measure Information:
Title
Delirium and sleep
Time Frame
3 days in ICU
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients ≥ 21 years will be recruited from a Trauma Intensive Care Unit of Puerto Rico. This unit receives critically ill patients with three or more affected body systems involved after motor vehicle accident, gunshot injury, penetrating injury, and falls.
Exclusion Criteria:
Baseline neurological diseases
Head trauma or acute neurological injury with Glasgow Coma Scale score < 8
Death expected within 24 hours (APACHE II ≥ 30)
History of alcoholism
History of drug dependence
Deaf and blind patients
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Geraldine V Padilla, PhD
Organizational Affiliation
The Regents of the University of California, San Francisco
Official's Role
Study Chair
Facility Information:
Facility Name
Trauma Unit University of Puerto Rico Medical Center
City
San Juan
Country
Puerto Rico
12. IPD Sharing Statement
Learn more about this trial
Effect of Daily Interruption of Continuous Sedation on Delirium, Sleep Perception in Intensive Care Unit (ICU) Patients
We'll reach out to this number within 24 hrs